INSIST! Multiple Myeloma
September 2022
Insist! on Better Care
Biomarker testing in multiple myeloma is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! Multiple Myeloma is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Testing in Multiple Myeloma
Multiple Myeloma Treatment Decisions
INSIST! Multiple Myeloma Resources
This program is supported by AbbVie, Bristol Myers Squibb/Celgene, Foundation Medicine, and Takeda, and through generous donations from people like you.
